Heidi Pusey
Nurse Practitioner · Jackson, MINPI 1194012302
Payments from drug & device makers
Across 132 payments — averaging $29.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Convatec Inc.$1K
- Otsuka America Pharmaceutical, Inc.$500
- AbbVie$335
- Grifols USA, LLC$226
- Lundbeck LLC$167
- Novo Nordisk$134
- plus $1K from 27 others
What the payments were for
- Travel & lodging$82221%
- Food & beverage$2,96577%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Convatec Inc. | 9 | $1,435 |
| Otsuka America Pharmaceutical, Inc. | 29 | $500 |
| AbbVie | 23 | $335 |
| Grifols USA, LLC | 5 | $226 |
| Lundbeck LLC | 10 | $167 |
| Novo Nordisk | 4 | $134 |
| Axsome Therapeutics, Inc. | 4 | $96 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $87 |
| GSK | 5 | $86 |
| Amgen | 4 | $62 |
| Medtronic | 1 | $62 |
| Mylan Specialty L.p. | 2 | $62 |
| Lilly USA, LLC | 3 | $56 |
| Sunovion Pharmaceuticals Inc. | 6 | $54 |
| Bayer | 3 | $53 |
| Exact Sciences | 3 | $51 |
| Organogenesis Inc. | 2 | $40 |
| Smith+Nephew | 1 | $35 |
| Surgenex LLC | 1 | $27 |
| Cashflow Solutions, LLC | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Viatris Specialty LLC | 1 | $22 |
| Boston Scientific | 1 | $22 |
| Reprise Biomedical, Inc. | 1 | $21 |
| Abbott | 1 | $20 |
| Merck | 1 | $20 |
| Boehringer Ingelheim | 1 | $20 |
| Radius Health, Inc. | 1 | $18 |
| Integra Lifesciences Corporation | 1 | $17 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Mimedx Group, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$1,192
- Prolastin-C Liquid$125
- REXULTI$122
How this compares
$3,834 in reported general payments places this provider in the 90th percentile of 3,351 nurse practitioner providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 53 | $51,740 |
| MounjaroTirzepatide | 42 | $47,970 |
| OxycontinOxycodone Hcl | 14 | $24,103 |
| OzempicSemaglutide | 20 | $21,696 |
| TrulicityDulaglutide | 16 | $14,907 |
| SantylCollagenase Clostridium Hist. | 15 | $13,649 |
| Spiriva HandihalerTiotropium Bromide | 15 | $11,577 |
| XareltoRivaroxaban | 13 | $10,946 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 15 | $4,400 |
| Hydrocodone-IbuprofenHydrocodone/Ibuprofen | 12 | $3,809 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 218 | $3,630 |
| Incruse ElliptaUmeclidinium Bromide | 11 | $3,392 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $2,791 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 85 | $2,285 |
| Fluticasone Propionate | 26 | $1,834 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $56 | $62,87658 claims |
| GSKTrelegy Ellipta, Incruse Ellipta | $86 | $55,13264 claims |
| Novo NordiskOzempic | $134 | $21,69620 claims |
| Smith+NephewSantyl | $35 | $13,64915 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,351 nurse practitioner providers in Michigan.
Other nurse practitioner in Jackson
- Davida KrugerDetroit$1.8M
- Kari HillSpring Lake$426K
- Kyle FarrPlymouth$243K
- Linda SpencerTroy$217K
- Ellen DillardDetroit$168K
- Golbon AghamohammadiDetroit$157K
- Abubakir BabanDearborn$143K
- Elizabeth KirshnerAnn Arbor$119K
- Lisa Astalos ChismWoodhaven$103K
- Martha GoetzPetoskey$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.